Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)Gladys Telliam, Ali G. Turhan, Radhia M’kacher et al.|Cancers|2023Cited by 12
Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment OutcomesJenny Bonifacio-Mundaca, Jorge Mata-Garrido, Íñigo Casafont et al.|Biomedicines|2025Cited by 6
Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) using patient-derived induced pluripotent stem cells (iPSC)Gladys Telliam, Ali G. Turhan, Christophe Desterke et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Comparative Transcriptome Analyses in Mantle Cell Lymphoma (MCL): Evidence of E2F1 As a Major Target in Aggressive Blastoid MCL ModelJusuf Imeri, Ali G. Turhan, Annelise Bennaceur‐Griscelli et al.|Blood|2023Cited by 0